Your clinicians already use AI, sanctioned or not. Your vendors ship AI features faster than your committees can review them. We help health systems adopt AI at the speed of trust: governed, measured, and safe for the patient in the room.
THE GAP
Staff paste into chatbots to save time. Vendors flip on AI features in tools you already licensed. Boards want an AI strategy while legal asks who approved the last one. Every ungoverned week adds exposure: PHI, compliance findings, patient trust. Treat it as a patient-safety decision that happens to involve technology, because that is exactly what it is.
THE GOVERNANCE LAYER · ONPOINT DNA™
The OnPoint DNA Discovery, our 14-day diagnostic, maps where AI already touches your workflows, where PHI sits exposed, and which initiatives deserve to move first. Then we build the governance frame (policy, review, and measurement) so your teams can say yes to AI quickly, safely, and provably.
WHERE WE START
ASSESS
Find every place AI already touches care and data, sanctioned and shadow, and get a plain-language picture your board and your CISO can both act on.
GOVERN
Policy and review processes built for clinical reality: fast enough that teams use them, rigorous enough that auditors and patients trust them.
ADOPT
Pilot-to-deployment execution for the AI initiatives that clear the bar, with adoption tracked, outcomes measured, and safety reviewed at every gate.
Bring one AI decision sitting on your desk right now: the vendor feature, the pilot request, the board mandate. In 14 days the OnPoint DNA Discovery gives you a governed, decision-ready answer. You keep it either way.
